Blueblood Ventures Limited Schedules Board Meeting on May 27, 2026 to Approve FY26 Financial Results
Blueblood Ventures Limited has intimated BSE Limited of a board meeting on May 27, 2026, at its New Delhi office, to approve audited standalone financial results for the half year and financial year ended March 31, 2026, under Regulation 29 of SEBI (LODR) Regulations, 2015. The trading window for designated persons has been closed since March 31, 2026, and is set to reopen on May 30, 2026.

*this image is generated using AI for illustrative purposes only.
Blueblood Ventures Limited has notified BSE Limited of an upcoming board meeting scheduled for Wednesday, May 27, 2026, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. The intimation, dated May 15, 2026, was submitted to the Secretary of BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai.
Board Meeting Details
The board meeting will be held at the company's registered address at M-55, Third Floor, Greater Kailash-II, New Delhi – 110048. The key agenda item for the meeting is outlined below:
| Parameter: | Details |
|---|---|
| Meeting Date: | Wednesday, May 27, 2026 |
| Venue: | M-55, Third Floor, Greater Kailash-II, New Delhi – 110048 |
| Agenda: | Approval of Audited Standalone Financial Results |
| Period Under Review: | Half year and financial year ended March 31, 2026 |
| Regulatory Basis: | Regulation 29, SEBI (LODR) Regulations, 2015 |
Trading Window Closure
In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code for regulating, monitoring, and reporting of trading in securities by designated persons, the trading window for all designated persons, including insiders, has been closed with effect from March 31, 2026. The trading window is scheduled to reopen on May 30, 2026.
Regulatory Compliance
The intimation was signed by Suresh Bohra, Managing Director of Blueblood Ventures Limited, and submitted for the information and records of BSE Limited. The company's contact details are as follows:
- Email: blueblood@blackfoxindia.com
- Website: www.bluebloodventure.com
How might Blueblood Ventures Limited's audited standalone financial results for FY2026 compare to its previous year's performance, and what growth trajectory could investors expect?
Will the board meeting on May 27, 2026 include any additional agenda items beyond financial results approval, such as dividend declarations or strategic announcements?
How could the trading window reopening on May 30, 2026 impact the stock's trading volume and price volatility following the release of the audited results?

























